Indiana’s life sciences initiative has named six finalists for its New Venture Competition. BioCrossroads will announce the winners Wednesday during the Indiana Life Science Summit in Indianapolis.
The finalists are:
Animated Dynamics, which provides clinical laboratory services for personalized cancer therapy selection.
Arrhythmotech, which has developed new devices and services to be used in the detection and analysis of sympathetic nerve activity.
Auricyte, which is developing what it calls a first-of-its-kind therapy for hearing loss.
Phytoption, which has developed a platform to transform high value, insoluble ingredients into soluble solutions for food, pharmaceutical, cosmetic and supplement uses.
Ossa Biomedical, which develops therapeutics for bone disorders.
SPEAK MODalities, which develops methods and learning aids to improve the quality of communications for people with Autism or language disabilities.
The winner will receive a cash prize of $25,000 and access to the Indiana Seed Fund II staff and network resources.